In vitro-in vivo correlation of efavirenz tablets using GastroPlus®
about
Population Pharmacokinetic Modeling To Estimate the Contributions of Genetic and Nongenetic Factors to Efavirenz Disposition.In vitro-in vivo correlations: general concepts, methodologies and regulatory applications.Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.Application of Absorption Modeling in Rational Design of Drug Product Under Quality-by-Design Paradigm.Azithromycin cationic non-lecithoid nano/microparticles improve bioavailability and targeting efficiency.
P2860
In vitro-in vivo correlation of efavirenz tablets using GastroPlus®
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vitro-in vivo correlation of efavirenz tablets using GastroPlus®
@en
In vitro-in vivo correlation of efavirenz tablets using GastroPlus®.
@nl
type
label
In vitro-in vivo correlation of efavirenz tablets using GastroPlus®
@en
In vitro-in vivo correlation of efavirenz tablets using GastroPlus®.
@nl
prefLabel
In vitro-in vivo correlation of efavirenz tablets using GastroPlus®
@en
In vitro-in vivo correlation of efavirenz tablets using GastroPlus®.
@nl
P2093
P2860
P1433
P1476
In vitro-in vivo correlation of efavirenz tablets using GastroPlus®
@en
P2093
Carlos Rangel Rodrigues
Eduardo Costa Pinto
Helena Carla Rangel Castro
Helvécio Vinicius A Rocha
Lucio Mendes Cabral
Tereza Cristina dos Santos
Thiago da Silva Honório
Valeria Pereira de Sousa
Valeria Sant'Anna Dantas Esteves
P2860
P2888
P304
P356
10.1208/S12249-013-0016-4
P407
P577
2013-08-14T00:00:00Z
P5875
P6179
1008309897